MSL
BDSI

Mackay Shields LLC’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Mackay Shields LLC’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-128,700
Closed -$503K – 1519
2021
Q1 		$503K Sell
128,700
-86,000
-40% -$355K ﹤0.01% 1209
2020
Q4 		$901K Sell
214,700
-330,600
-61% -$1.27M 0.01% 1106
2020
Q3 		$2.03M Sell
545,300
-11,800
-2% -$50.2K 0.01% 783
2020
Q2 		$2.43M Buy
557,100
+29,400
+6% +$132K 0.02% 672
2020
Q1 		$2M Buy
527,700
+12,700
+2% +$62.4K 0.02% 664
2019
Q4 		$3.25M Sell
515,000
-90,900
-15% -$534K 0.02% 678
2019
Q3 		$2.55M Buy
605,900
+240,200
+66% +$1.03M 0.02% 799
2019
Q2 		$1.7M Buy
+365,700
New +$1.7M 0.01% 964

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mackay Shields LLC's BDSI Position: Q2 2021 in Review

Mackay Shields LLC sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2021, closing a stake of 128,700 shares — an estimated $503K sold.

Mackay Shields LLC first reported a position in BDSI in Q2 2019 and held it in 8 quarters. The position peaked at $3.25M in Q4 2019. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2021.

  • Mackay Shields LLC reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 128,700 BioDelivery Sciences International, Inc. shares in Q2 2021, an estimated $503K.
  • Mackay Shields LLC first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 8 quarters.
  • Mackay Shields LLC's BioDelivery Sciences International, Inc. position peaked at $3.25M in Q4 2019.
  • 143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.